The Tim Ferriss Show

#458: The Psychedelic News Hour: New Breakthroughs, Compound Comparisons and Warnings (Psilocybin/LSD/Ayahuasca/N,N-DMT/5-MeO-DMT), Treatment of Trauma, Scalable vs. Unscalable Approaches, Making Sense of “Bad” Trips, and Much More

15 snips
Sep 3, 2020
In a thought-provoking discussion, Dr. David Rabin, a board-certified psychiatrist and co-founder of Apollo Neuroscience, and Dr. Molly Maloof, a physician and Stanford lecturer, dive into the world of psychedelic-assisted psychotherapy. They explore breakthroughs in treating trauma, emphasizing the importance of a supportive environment. The duo highlights the role of diverse funding in advancing research and the ethical implications within the psychedelic community. They also address coping strategies for challenging trips and the integration of technology in mental health care.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ADVICE

Psychedelic Preparation

  • Approach psychedelics with serious preparation, like major surgery.
  • Allocate sufficient time, have support, and prioritize safety.
INSIGHT

Street Drug Risks

  • Street psychedelics have inconsistent quality and unknown adulterants.
  • This poses significant risks, especially with MDMA.
ANECDOTE

Scaling Challenges

  • Molly Maloof expresses concern about scaling psychedelic treatments.
  • She questions how to reach a wider audience beyond expensive individual therapy.
Get the Snipd Podcast app to discover more snips from this episode
Get the app